---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-199061"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:20:12.030913+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fulgent Q1 2026: GAAP EPS -$0.80, revenue $71.1M, reiterates FY2026 guidance

## Summary
- GAAP net loss of $24.8M ($0.80/share); non-GAAP loss of $11.0M ($0.36/share).
- Revenue $71.1M; GAAP gross margin 30.2%, non-GAAP gross margin 32.3%.
- Adjusted EBITDA loss of $15.2M in Q1 2026.
- Cash, equivalents, restricted cash & marketable securities $604.7M; expects ~$106M tax refund.
- Bought back ~2.6M shares for $40.1M in Q1; FY2026 revenue guidance reaffirmed.

## SEC filing metadata
- accession: 0001193125-26-199061
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000119312526199061/0001193125-26-199061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000119312526199061/flgt-20260501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-199061
- JSON: https://secwatch.observer/filing/0001193125-26-199061.json
- Plain text: https://secwatch.observer/filing/0001193125-26-199061.txt

## Key facts
- Earnings Releases
  Fulgent Genetics, Inc. reported first quarter ended March 31, 2026 results: revenue 71.1 million, net income -24.8 million, EPS -0.80. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2026
  - Revenue: 71.1 million
  - Net income: -24.8 million
  - EPS: -0.80
  - Guidance: reaffirmed
  - Result: reported results
  source text: for fiscal year 2026 • Executed on stock repurchase program; purchased approximately 2.6 million shares in the first quarter of 2026 using $40.1 million in cash • Revenue of $71.1 million • GAAP gross profit of $21.5 million, or GAAP gross margin of 30.2%; Non-GAAP gross profit of $23.0 million, or Non-GAAP gross margin of 32.3% • GAAP loss of $24.8 million, or
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000119312526199061/0001193125-26-199061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.